260 related articles for article (PubMed ID: 26074264)
1. Arctigenin exerts anti-colitis efficacy through inhibiting the differentiation of Th1 and Th17 cells via an mTORC1-dependent pathway.
Wu X; Dou Y; Yang Y; Bian D; Luo J; Tong B; Xia Y; Dai Y
Biochem Pharmacol; 2015 Aug; 96(4):323-36. PubMed ID: 26074264
[TBL] [Abstract][Full Text] [Related]
2. Arctigenin functions as a selective agonist of estrogen receptor β to restrict mTORC1 activation and consequent Th17 differentiation.
Wu X; Tong B; Yang Y; Luo J; Yuan X; Wei Z; Yue M; Xia Y; Dai Y
Oncotarget; 2016 Dec; 7(51):83893-83906. PubMed ID: 27863380
[TBL] [Abstract][Full Text] [Related]
3. Arctigenin but not arctiin acts as the major effective constituent of Arctium lappa L. fruit for attenuating colonic inflammatory response induced by dextran sulfate sodium in mice.
Wu X; Yang Y; Dou Y; Ye J; Bian D; Wei Z; Tong B; Kong L; Xia Y; Dai Y
Int Immunopharmacol; 2014 Dec; 23(2):505-15. PubMed ID: 25284342
[TBL] [Abstract][Full Text] [Related]
4. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
[TBL] [Abstract][Full Text] [Related]
5. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile.
Hu S; Chen M; Wang Y; Wang Z; Pei Y; Fan R; Liu X; Wang L; Zhou J; Zheng S; Zhang T; Lin Y; Zhang M; Tao R; Zhong J
PLoS One; 2016; 11(4):e0154564. PubMed ID: 27128484
[TBL] [Abstract][Full Text] [Related]
6. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages.
Hyam SR; Lee IA; Gu W; Kim KA; Jeong JJ; Jang SE; Han MJ; Kim DH
Eur J Pharmacol; 2013 May; 708(1-3):21-9. PubMed ID: 23375938
[TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
[TBL] [Abstract][Full Text] [Related]
8. Oxymatrine protects against DSS-induced colitis via inhibiting the PI3K/AKT signaling pathway.
Chen Q; Duan X; Fan H; Xu M; Tang Q; Zhang L; Shou Z; Liu X; Zuo D; Yang J; Deng S; Dong Y; Wu H; Liu Y; Nan Z
Int Immunopharmacol; 2017 Dec; 53():149-157. PubMed ID: 29107215
[TBL] [Abstract][Full Text] [Related]
9. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation.
Li C; Xi Y; Li S; Zhao Q; Cheng W; Wang Z; Zhong J; Niu X; Chen G
Mol Immunol; 2015 Oct; 67(2 Pt B):444-54. PubMed ID: 26224047
[TBL] [Abstract][Full Text] [Related]
10. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
[TBL] [Abstract][Full Text] [Related]
11. 1,25-dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 and Th17 activation.
Zhang H; Wu H; Liu L; Li H; Shih DQ; Zhang X
APMIS; 2015 Jun; 123(6):490-501. PubMed ID: 25907285
[TBL] [Abstract][Full Text] [Related]
12. Fisetin regulates obesity by targeting mTORC1 signaling.
Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
[TBL] [Abstract][Full Text] [Related]
13. Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response.
Liu W; Guo W; Guo L; Gu Y; Cai P; Xie N; Yang X; Shu Y; Wu X; Sun Y; Xu Q
Int Immunopharmacol; 2014 Jun; 20(2):337-45. PubMed ID: 24704625
[TBL] [Abstract][Full Text] [Related]
14. Brazilian propolis ameliorates trinitrobenzene sulfonic acid-induced colitis in mice by inhibiting Th1 differentiation.
Okamoto Y; Hara T; Ebato T; Fukui T; Masuzawa T
Int Immunopharmacol; 2013 Jun; 16(2):178-83. PubMed ID: 23602915
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.
Acharya S; Timilshina M; Jiang L; Neupane S; Choi DY; Park SW; Lee SY; Jeong BS; Kim JA; Nam TG; Chang JH
Sci Rep; 2018 May; 8(1):7799. PubMed ID: 29773813
[TBL] [Abstract][Full Text] [Related]
16. IL-33 alleviates DSS-induced chronic colitis in C57BL/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response.
Zhu J; Wang Y; Yang F; Sang L; Zhai J; Li S; Li Y; Wang D; Lu C; Sun X
Int Immunopharmacol; 2015 Dec; 29(2):846-853. PubMed ID: 26359542
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic effects of Lonicera japonica extract on dextran sulphate sodium-induced colitis in a mouse model by the inhibition of the Th1/Th17 response.
Park JW; Bae H; Lee G; Hong BG; Yoo HH; Lim SJ; Lee K; Kim J; Ryu B; Lee BJ; Bae J; Lee H; Bu Y
Br J Nutr; 2013 Jan; 109(2):283-92. PubMed ID: 22569277
[TBL] [Abstract][Full Text] [Related]
18. Inonotus obliquus polysaccharide ameliorates dextran sulphate sodium induced colitis involving modulation of Th1/Th2 and Th17/Treg balance.
Chen YF; Zheng JJ; Qu C; Xiao Y; Li FF; Jin QX; Li HH; Meng FP; Jin GH; Jin D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):757-766. PubMed ID: 30856346
[TBL] [Abstract][Full Text] [Related]
19. Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models.
Guan Y; Zhang L; Li X; Zhang X; Liu S; Gao N; Li L; Gao G; Wei G; Chen Z; Zheng Y; Ma X; Siwko S; Chen JL; Liu M; Li D
J Immunol; 2015 Jul; 195(1):339-46. PubMed ID: 26026060
[TBL] [Abstract][Full Text] [Related]
20. Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis.
Bai A; Yong M; Ma AG; Ma Y; Weiss CR; Guan Q; Bernstein CN; Peng Z
J Pharmacol Exp Ther; 2010 Jun; 333(3):717-25. PubMed ID: 20237071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
